首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: An unusual complication in ulcerative colitis during treatment with azathioprine and infliximab: Isospora belli as ‘Casus belli’
【2h】

Case Report: An unusual complication in ulcerative colitis during treatment with azathioprine and infliximab: Isospora belli as ‘Casus belli’

机译:病例报告:在用硫唑嘌呤和英夫利昔单抗治疗期间溃疡性结肠炎的异常并发症:贝索氏菌为“卡索氏菌”

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The treatment of ulcerative colitis is based on systemic corticosteroids, immunomodulators such as cyclosporine and azathioprine and TNF-α antagonists. Patients undergoing such immunosuppressive treatment are more susceptible for infectious pathogens. Here, we report the case of a patient with a 13-year history of ulcerative colitis, treated initially with systemic corticosteroids in combination with immunomodulators, and subsequently with infliximab. The patient presented with severe watery diarrhoea, abdominal cramps, weight loss and low-grade fever. Stool examinations for cytomegalovirus, bacteria and parasites were negative. Following detection of numerous oocytes of Isospora belli (IB) in direct smear preparations of the diarrhoeic stool samples, the patient was successfully treated with trimethoprim-sulfamethoxazole (co-trimoxazole).
机译:溃疡性结肠炎的治疗基于全身性皮质类固醇,免疫调节剂(例如环孢素和硫唑嘌呤)和TNF-α拮抗剂。接受这种免疫抑制治疗的患者更容易感染传染性病原体。在这里,我们报道了一名溃疡性结肠炎病史为13年的患者,该患者最初先用全身性皮质类固醇与免疫调节剂联合治疗,然后再用英夫利昔单抗治疗。该患者出现严重的水样腹泻,腹部绞痛,体重减轻和低烧。粪便检查中巨细胞病毒,细菌和寄生虫呈阴性。在腹泻粪便样本的直接涂片制剂中检测到大量的Isospora belli(IB)卵母细胞后,用甲氧苄氨嘧啶-磺胺甲基异恶唑(co-trimoxazole)成功治疗了该患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号